[1] Christopher W Espelin, et al. Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer. Cancer Res. 2016 Mar 15;76(6):1517-27. DOI:
10.1158/0008-5472.CAN-15-1518